Last reviewed · How we verify
No one
At a glance
| Generic name | No one |
|---|---|
| Sponsor | Nearmedic Plus LLC |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Immediate Restoration of a New Implant With High Primary Stability (NA)
- Dyadic Management Intervention in Older People With Co-occurring Cognitive Impairment and Diabetes as a Supplementary Approach to Chronic Diseases Self-Management Program (NA)
- Ischemic Preconditioning Reduces the Severity of Acute Kidney Injury After Partial Nephrectomy (NA)
- Cognitive Task Development and Implementation for Functional MRI Studies
- Structured Breastfeeding Education In Infants With Breast Refusal (NA)
- Spot Analysis of Natriuresis to Guide up- or Down-titration of Diuretic Therapy in Ambulatory Patients With Chronic Heart Failure (NA)
- Study of Families With Twins or Siblings Discordant for Rheumatic Disorders
- Perceptions of Proposed Warnings for Cannabis Edibles Packaging (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- No one CI brief — competitive landscape report
- No one updates RSS · CI watch RSS
- Nearmedic Plus LLC portfolio CI